166 related articles for article (PubMed ID: 23428174)
21. Clinicopathologic analysis of acute vascular rejection cases after renal transplantation.
Shimizu T; Tanabe T; Omoto K; Ishida H; Tanabe K
Transplant Proc; 2012 Jan; 44(1):230-5. PubMed ID: 22310621
[TBL] [Abstract][Full Text] [Related]
22. Characterization of intra-graft B cells during renal allograft rejection.
Zarkhin V; Kambham N; Li L; Kwok S; Hsieh SC; Salvatierra O; Sarwal MM
Kidney Int; 2008 Sep; 74(5):664-73. PubMed ID: 18547992
[TBL] [Abstract][Full Text] [Related]
23. Late acute liver allograft rejection; a study of its natural history and graft survival in the current era.
Thurairajah PH; Carbone M; Bridgestock H; Thomas P; Hebbar S; Gunson BK; Shah T; Neuberger J
Transplantation; 2013 Apr; 95(7):955-9. PubMed ID: 23442806
[TBL] [Abstract][Full Text] [Related]
24. Distribution and expression of fibroblast-specific protein chemokine CCL21 and chemokine receptor CCR7 in renal allografts.
Zhou HL; Wang YT; Gao T; Wang WG; Wang YS
Transplant Proc; 2013 Mar; 45(2):538-45. PubMed ID: 23498789
[TBL] [Abstract][Full Text] [Related]
25. Designation of T-cell-mediated rejection type Ib and IIa reflects the type of rejection rather than the severity in the Banff classification.
Wu K; Budde K; Schmidt D; Neumayer HH; Rudolph B
Exp Clin Transplant; 2014 Oct; 12(5):415-23. PubMed ID: 25299369
[TBL] [Abstract][Full Text] [Related]
26. The presence of B-cell nodules does not necessarily portend a less favorable outcome to therapy in patients with acute cellular rejection of a renal allograft.
Doria C; di Francesco F; Ramirez CB; Frank A; Iaria M; Francos G; Marino IR; Farber JL
Transplant Proc; 2006 Dec; 38(10):3441-4. PubMed ID: 17175297
[TBL] [Abstract][Full Text] [Related]
27. Endothelial chimerism after ABO-incompatible kidney transplantation.
Tanabe T; Ishida H; Horita S; Honda K; Yamaguchi Y; Nonomura K; Tanabe K
Transplantation; 2012 Apr; 93(7):709-16. PubMed ID: 22456486
[TBL] [Abstract][Full Text] [Related]
28. Long-term allograft survival after kidney transplantation.
Gómez EG; Hernández JP; López FJ; Garcia JR; Montemayor VG; Curado FA; Vallejo ML; López JC; Cabello MD; Aljama P; Tapia MJ
Transplant Proc; 2013; 45(10):3599-602. PubMed ID: 24314970
[TBL] [Abstract][Full Text] [Related]
29. The impact of C4d staining as a humoral injury marker.
Kara M; Demir F; Ata P; Ozel L; Gumrukcu G; Unal E; Canbakan M; Gucun M; Esadoglu V; Ozdemir E; Cemel H; Titiz MI
Transplant Proc; 2012; 44(6):1694-6. PubMed ID: 22841245
[TBL] [Abstract][Full Text] [Related]
30. The diagnostic value of detection of CD20 positive infiltrates in renal biopsies with acute allograft rejection: a pilot study.
Genina A; Ismail W; Soliman AR
Arab J Nephrol Transplant; 2014 May; 7(2):97-101. PubMed ID: 25366504
[TBL] [Abstract][Full Text] [Related]
31. Vascular expression of adhesion molecules in acute and chronic rejection of kidney allografts.
Jurcić V; Ferluga D
Adv Clin Path; 2003 Jan; 7(1):33-7. PubMed ID: 19774735
[TBL] [Abstract][Full Text] [Related]
32. Donor-recipient age difference and graft survival in living donor kidney transplantation.
Lee YJ; Chang JH; Choi HN; Jung JY; Kim YS; Chung WK; Park YH; Lee HH
Transplant Proc; 2012 Jan; 44(1):270-2. PubMed ID: 22310630
[TBL] [Abstract][Full Text] [Related]
33. Advantages of kidney transplant precocity in graft long-term survival.
Malho A; Malheiro J; Fonseca I; Martins LS; Pedroso S; Almeida M; Dias L; Castro Henriques A; Cabrita A
Transplant Proc; 2012 Oct; 44(8):2344-7. PubMed ID: 23026589
[TBL] [Abstract][Full Text] [Related]
34. Genetic association of FOXP3 gene polymorphisms with allograft rejection in renal transplant patients.
Qiu XY; Jiao Z; Zhang M; Chen JP; Shi XJ; Zhong MK
Nephrology (Carlton); 2012 May; 17(4):423-30. PubMed ID: 22239151
[TBL] [Abstract][Full Text] [Related]
35. Interleukin-2 receptor antibody does not reduce rejection risk in low immunological risk or tacrolimus-treated intermediate immunological risk renal transplant recipients.
Lim WH; Chadban SJ; Campbell S; Dent H; Russ GR; McDonald SP
Nephrology (Carlton); 2010 Apr; 15(3):368-76. PubMed ID: 20470309
[TBL] [Abstract][Full Text] [Related]
36. Effects of CD20+ B-cell infiltration into allografts on kidney transplantation outcomes: a systematic review and meta-analysis.
Lu Y; Li B; Shen Q; Wang R; Chen Z; Jiang H; Chen J
Oncotarget; 2017 Jun; 8(23):37935-37941. PubMed ID: 28415773
[TBL] [Abstract][Full Text] [Related]
37. Do intraoperative hemodynamic factors of the recipient influence renal graft function?
Campos L; Parada B; Furriel F; Castelo D; Moreira P; Mota A
Transplant Proc; 2012; 44(6):1800-3. PubMed ID: 22841277
[TBL] [Abstract][Full Text] [Related]
38. Relation between pretransplant serum levels of soluble CD30 and acute rejection during the first 6 months after a kidney transplant.
Shooshtarizadeh T; Mohammadali A; Ossareh S; Ataipour Y
Exp Clin Transplant; 2013 Jun; 11(3):229-33. PubMed ID: 23477385
[TBL] [Abstract][Full Text] [Related]
39. Expression of class II major histocompatibility complex antigens (HLA-DR) and lymphocyte subset immunotyping in chronic pulmonary transplant rejection.
Hasegawa S; Ockner DM; Ritter JH; Patterson GA; Trulock EP; Cooper JD; Wick MR
Arch Pathol Lab Med; 1995 May; 119(5):432-9. PubMed ID: 7748071
[TBL] [Abstract][Full Text] [Related]
40. Impact of pancreatic allograft function on 1-year survival rates after simultaneous pancreatic-renal transplant.
Rangel EB; Melaragno CS; Gonzalez AM; Linhares MM; de Sa JR; Salzedas A; Medina-Pestana JO
Exp Clin Transplant; 2008 Dec; 6(4):301-6. PubMed ID: 19338493
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
